De Tijd publishes Op-ed of Belgian signatories
Today, leading Belgian newspaper De Tijd published an Op-ed co-signed by several BSP signatories on the potential and future of Belgian and EU biotech. The Belgian biotech sector is world class in terms of innovation and R&D and a key pillar of the economy. The authors argue that biotech in Belgium has considerable potential, especially […]
Launch of Biotech Social Pact social media accounts!
We are delighted to announce the launch of the social media accounts of the Biotech Social Pact. As of now we can be found on LinkedIn and Twitter. You can also access our social media through the LinkedIn and Twitter logos on the BSP website, which be found at the bottom of the home page. […]
The Pharma Letter publishes OpEd from Amicus Therapeutics’ John Crowley, BSP Co-Author and Executive Chairman and Charlie Galvin, General Manager for the UK and Ireland
Earlier this year, leading UK pharmaceutical trade outlet The Pharma Letter published an OpEd from Amicus Therapeutics’ Executive Chairman John Crowley and General Manager for the UK and Ireland Charlie Galvin, who wrote on the industry’s obligation to ensure the value created through innovation is shared with both patients and health systems alike. This OpEd […]
BSP Quarterly Signatory Newsletter – Q3 2022
Quarterly Newsletter – Q3 2022 We have been immensely pleased with the strong showing of the Biotech Social Pact (BSP) throughout our markets this year. In this second iteration of our quarterly newsletter, you will find below an overview of recent BSP achievements and news coverage, of upcoming activities, and our current calls to action […]
A New Chapter of the Biotech Social Pact is Launched in Portugal
On 19th September at the BioMeet 2022 Congress in in Oeiras, Portugal, the Portuguese Chapter of the BSP was officially launched. We are overjoyed that the BSP and its mission continues to grow across Europe! The Pact was signed by no less than 14 Portuguese biotech leaders in the company of an esteemed audience, which […]
Des membres du Biotech Social Pact appellent à la création d’un secrétariat d’Etat à la Biotechnologie
Alors que le président Macron a fixé pour objectif de développer et de produire 20 médicaments biopharmaceutiques d’ici 2030, plusieurs membres du Contrat Social pour la Biotechnologie appellent à la nomination d’un secrétaire d’Etat dédié à la biotechnologie dans le prochain gouvernement, afin de favoriser l’innovation en santé et la croissance de l’écosystème biotech français. […]
Members of the Biotech Social Pact call for the creation of a State Secretariat for Biotechnology
As President Macron has set the goal of developing and producing 20 biopharmaceutical products by 2030 in France, several members of the Biotech Social Pact call for the appointment of a Minister for Biotechnology in the next Government, to foster health innovation and the growth of the French biotech ecosystem. Whereas healthcare is currently undergoing a major biotechnological […]
